Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection

Indian Journal of Medical Research

Volumn 123, Issue 1, 2006, Pages 37-42

  Behzad Behbahani, A ^a   Mafi Nejad, A ^a   Tabei, S Z ^a   Lankarani, K B ^b   Torab, A ^c   Moaddeb, A ^d  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti HBc; HBV DNA; Health blood donors; Hepatitis B virus infection

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE TRANSMISSION; ENZYME IMMUNOASSAY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HUMAN; INFECTION CONTROL; INFECTION RISK; IRAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; POLYMERASE CHAIN REACTION; POPULATION DISTRIBUTION; RISK REDUCTION; SERODIAGNOSIS; SEROPREVALENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; BLOOD DONORS; BLOOD TRANSFUSION; COMMUNICABLE DISEASES; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IRAN; MALE; MASS SCREENING; MIDDLE AGED; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 33645467140     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334 : 1685-90.
2. Saraswat S, Banerjee K, Chaudhury N, Mahant T, Khandekar P, Gupta RK, et al. Post-transfusion hepatitis type B following multiple transfusions of HBsAg-negative blood. J Hepatol 1996; 25 : 639-43.
3. Jongerius JM, Wester M, Cuypers HT, van Oostendorp WR, Lelie PN, van der Poel CL, et al. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion 1998; 38 : 56-9.
4. Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 1997; 4 (Suppl 1) : 11-20.
5. Carman WF, Mimms LT. Pre-S/S gene variants of hepatitis B virus. In: Rizzetto M, Purcell RH, Gerin JL, Verne G, editors. Viral hepatitis and liver disease. Torino, Italy: Edizioni Minerva Medica; 1997 p. 108-15.
6. Tsai S, Liaw Y, Yeh C, Chu CM, Kuo GC. Cellular immune responses in patients with dual infection of hepatitis B and C viruses: dominant role of hepatitis C virus. Hepatology 1995; 21 : 908-12.
7. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337 : 1733-45.
8. Ben Ayed M, Triki H, Cointe D, Karray H, Masmoudi MA, Dellagi K, et al. The isolated presence of anti-HBc antibodies: prevalence and interpretation based on the results of viral DNA research and anti-HBs antibodies measurement after vaccination. Ann Biol Clin (Paris) 2001; 59 : 53-60.
9. Gomes SA, Yoshida CF, Niel C. Detection of hepatitis B virus DNA in hepatitis B surface antigen-negative serum by polymerase chain reaction: evaluation of different primer pairs and conditions. Acta Virol 1996; 40 : 133-8.
10. Iizuka H, Ohmura K, Ishijima A, Satoh K, Tanaka T, Tsuda F, et al. Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang 1992; 63 : 107-11.
11. Zervou EK, Dalekos GN, Boumba DS, Tsianos EV. Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece. Transfusion 2001; 41 : 652-8.
12. Malekzadeh R, Khatibian M, Rezvan H. Viral hepatitis in the world and Iran. J Iranian Med Council 1997; 15 : 183-200.
13. Merat SH, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iranian Med 2000; 3 : 192-201.
14. Amini S, Mahmoodi MF, Andalibi S, Solati AA. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study. J Trop Med Hyg 1993; 96 : 277-87.
15. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339 : 237-8.
16. Gish RG, Lau JY, Brooks L, Fang JW, Steady SL, Imperial JC, et al. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology 1996; 23 : 1-7.
17. Bernvil SS, Andrews V, Kuhns MC, McNamara AL. Hepatitis B core antigen antibody as an indicator of a low grade carrier state for hepatitis B virus in a Saudi Arabian blood donor population. Transfus Sci 1997; 18 : 49-53.
18. Torii N, Hasegawa K, Joh R, Hayashi N. Configuration and replication competence of hepatitis B virus DNA in peripheral blood mononuclear cells from chronic hepatitis B patients and patients who have recovered from acute self-limited hepatitis. Hepatol Res 2003; 25 : 234-43.
19. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 2001; 34 : 194-203.
20. Hennig H, Puchta I, Luhm J, Schlenke P, Goerg S, Kirchner H. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Blood 2002; 100 : 2637-41.
21. Roche B, Feray C, Gigou M, Roque-Afonso AM, Arulnaden JL, Delvart V, et al. HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis. Hepatology 2003; 38 : 86-95.
22. Seddigh-Tonekaboni S, Waters JA, Jeffers S, Gehrke R, Ofenloch B, Horsch A, et al. Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 2000; 60 : 113-21.
23. Nandi J, Benerjee K. Detection of hepatitis B virus DNA in donor blood by the polymerase chain reaction. Natl Med J India 1992; 5 : 5-7.